Tag: PNAT

Big Finish to a Winning Week

Options Reviews 

To close out what has been a very interesting trading week, we will start by going over our winning options plays from yesterday morning’s premarket report. We had signaled some ideas in the RAD and ACN chains that put up quite a nice intraday performance.

The targets to which we are specifically referring were the RAD Weekly $13.50-14.40 Calls and the ACN Weekly $207.50-212.50 Calls. All of the sets in those ranges produced notable moves on the day:

RAD Weekly $13.50-14.50 Calls
$13.50:  .86-3.15 (+266%)
$14: .59-2.69 (+356%)
$14.50: .34-2.11 (+521%)

We’re going to refresh our idea here and roll up to the RAD Weekly $16-16.50 Calls* as well this morning.

*Please do not attempt to trade weekly options on a Friday unless you are an advanced trader with access to disposable funds!
_____

ACN Weekly $207.50-212.50 Calls
$207.50:  4.22-10.50 (+149%)
$210: 3.50-8.23 (+135%)
$212.50 2.02-6.00 (+197%)
____

Fresh Options Ideas:
PRGS 07/17 $40 Calls
SNX 07/17 $115-120 Calls 


Other Updates

We’ve also got a few other stock calls that have exploded toward the end of this week, illustrating the excellence we regularly exhibit in seeking out all types of gain opportunities:

Vaxart, Inc. VXRT
Alerted: 06/25 |  Range: 3.45-12.28 | Gain: 256%
____

AeroVironmentB Inc. AVAV
Alerted: 06/24 |  Range: 1.65-6.30 | Gain: 282%
____

Global Arena Holding Inc. GAHC
Alerted: 06/25 |  Range: .0027-.015 | Gain: 456%

Extended Watchlist:
ALYI, PNAT, EKSO, DLCR, BLIC

Sticking with SPY Puts

Solid Hits on the SPY

We try to formulate new options ideas for a given session as often as we can without forcing the issue, and on most days we produce at least one. Yesterday, we designated our sole set of new contracts to watch as the SPY Weekly $250-248 Puts, and thanks to a painful day for the markets, we were afforded the chance to score some pretty nice intraday gains.

Two out of three of those strike points translated into instant double-bag opportunities, with the third falling just 1% short of that mark, providing the following moves on the day: 

SPY Weekly $250-248 Puts
$250: 4.39-8.73 (+99%)
$249: 4.00-8.10 (+103%)
$248: 3.65-7.50 (+105%)
______

Fresh Ideas:
SPY Weekly $244-242 Puts
WBA Weekly $44-45 Calls
KMX Weekly $50-55 Calls


CytoDyn, Inc. CYDY

We began tracking CYDY on Tuesday morning, and in addition to making a nominal move on the chart, the company has also put out some coronavirus related press in the couple days. One of the company’s investigational drugs which is about to enter Phase 2b/3 trials, has demonstrated a promising level of  efficacy among severe COVID-19 patients.

The stock itself has run from 2.65-3.09 in the past couple of sessions, which marks a move of just 17% but we’re going to be interested to continue tracking its performance in light of the company’s announcements.

VANCOUVER, Washington, April 02, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the three-day effect of leronlimab in eight severely ill COVID-19 patients demonstrated a significant improvement in several important immunologic bio-markers.  Patient test data reveals improvement in cytokines, IL-6, and a trend toward the normalization of the CD4/CD8 ratio. (>>View Full PR)


Extended Watchlist:
GRYO, PNAT, ROTH, SOLI, CTYX, IPIX